Annual EBIT
-$7.69 M
+$3.36 M+30.40%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual earnings before interest & taxes is -$7.69 million, with the most recent change of +$3.36 million (+30.40%) on December 31, 2023.
- During the last 3 years, TENX annual EBIT has risen by +$2.16 million (+21.96%).
- TENX annual EBIT is now -754.08% below its all-time high of -$900.00 thousand, reached on April 30, 1999.
Performance
TENX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.95 M
-$387.70 K-10.87%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly earnings before interest & taxes is -$3.95 million, with the most recent change of -$387.70 thousand (-10.87%) on September 30, 2024.
- Over the past year, TENX quarterly EBIT has dropped by -$163.30 thousand (-4.31%).
Performance
TENX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$14.54 M
-$1.99 M-15.84%
September 30, 2024
Summary
- As of February 8, 2025, TENX TTM earnings before interest & taxes is -$14.54 million, with the most recent change of -$1.99 million (-15.84%) on September 30, 2024.
- Over the past year, TENX TTM EBIT has dropped by -$4.46 million (-44.22%).
Performance
TENX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TENX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.4% | -4.3% | -44.2% |
| 3 y3 years | +22.0% | -260.4% | -82.6% |
| 5 y5 years | -11.5% | -260.4% | -82.6% |
TENX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.3% | -260.4% | at low | -107.3% | +55.2% |
| 5 y | 5-year | at high | +76.3% | -260.4% | +83.3% | -107.3% | +55.2% |
| alltime | all time | -754.1% | +76.3% | <-9999.0% | +83.3% | <-9999.0% | +55.2% |
Tenax Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.95 M(+10.9%) | -$14.54 M(+15.8%) |
| Jun 2024 | - | -$3.57 M(-5.9%) | -$12.55 M(+24.5%) |
| Mar 2024 | - | -$3.79 M(+17.6%) | -$10.08 M(+31.1%) |
| Dec 2023 | -$7.69 M(-30.4%) | -$3.22 M(+63.9%) | -$7.69 M(+9.6%) |
| Sep 2023 | - | -$1.97 M(+79.2%) | -$7.01 M(-11.9%) |
| Jun 2023 | - | -$1.10 M(-21.6%) | -$7.96 M(-18.1%) |
| Mar 2023 | - | -$1.40 M(-45.1%) | -$9.72 M(-11.9%) |
| Dec 2022 | -$11.04 M(-66.0%) | -$2.55 M(-12.6%) | -$11.04 M(-5.7%) |
| Sep 2022 | - | -$2.92 M(+2.0%) | -$11.71 M(-7.0%) |
| Jun 2022 | - | -$2.86 M(+5.2%) | -$12.59 M(+10.0%) |
| Mar 2022 | - | -$2.72 M(-15.3%) | -$11.44 M(-64.8%) |
| Dec 2021 | -$32.47 M(+229.7%) | -$3.21 M(-15.5%) | -$32.47 M(+1.2%) |
| Sep 2021 | - | -$3.80 M(+121.3%) | -$32.09 M(+5.2%) |
| Jun 2021 | - | -$1.72 M(-92.8%) | -$30.51 M(-1.4%) |
| Mar 2021 | - | -$23.75 M(+739.4%) | -$30.94 M(+214.1%) |
| Dec 2020 | -$9.85 M(+17.3%) | -$2.83 M(+27.5%) | -$9.85 M(+0.4%) |
| Sep 2020 | - | -$2.22 M(+3.4%) | -$9.81 M(-0.0%) |
| Jun 2020 | - | -$2.15 M(-19.2%) | -$9.82 M(+4.1%) |
| Mar 2020 | - | -$2.65 M(-4.9%) | -$9.43 M(+11.8%) |
| Dec 2019 | -$8.39 M(+21.8%) | -$2.79 M(+25.5%) | -$8.44 M(+7.2%) |
| Sep 2019 | - | -$2.22 M(+26.2%) | -$7.87 M(+9.3%) |
| Jun 2019 | - | -$1.76 M(+6.0%) | -$7.20 M(-1.7%) |
| Mar 2019 | - | -$1.66 M(-25.4%) | -$7.33 M(+6.4%) |
| Dec 2018 | -$6.89 M(-25.1%) | -$2.23 M(+43.3%) | -$6.89 M(+14.0%) |
| Sep 2018 | - | -$1.55 M(-17.7%) | -$6.05 M(+4.2%) |
| Jun 2018 | - | -$1.89 M(+54.4%) | -$5.80 M(-16.2%) |
| Mar 2018 | - | -$1.22 M(-11.5%) | -$6.93 M(-24.7%) |
| Dec 2017 | -$9.21 M(-52.5%) | -$1.38 M(+5.5%) | -$9.21 M(-25.4%) |
| Sep 2017 | - | -$1.31 M(-56.5%) | -$12.33 M(-20.6%) |
| Jun 2017 | - | -$3.01 M(-13.8%) | -$15.52 M(-9.6%) |
| Mar 2017 | - | -$3.50 M(-22.4%) | -$17.18 M(-11.4%) |
| Dec 2016 | -$19.39 M(+92.6%) | -$4.51 M(+0.2%) | -$19.39 M(+30.3%) |
| Sep 2016 | - | -$4.50 M(-3.7%) | -$14.88 M(-11.6%) |
| Jun 2016 | - | -$4.67 M(-18.1%) | -$16.82 M(+10.8%) |
| Mar 2016 | - | -$5.71 M(+61.9%) | -$15.18 M(-25.1%) |
| Dec 2015 | -$10.07 M(-28.3%) | - | - |
| Oct 2015 | - | -$3.52 M(+20.7%) | -$20.27 M(+21.0%) |
| Sep 2015 | - | -$2.92 M(-3.7%) | -$16.74 M(-6.3%) |
| Jul 2015 | - | -$3.03 M(-39.2%) | -$17.88 M(+5.4%) |
| Apr 2015 | -$14.03 M(-19.0%) | -$4.99 M(+69.7%) | -$16.97 M(+41.6%) |
| Mar 2015 | - | -$2.94 M(+2.4%) | -$11.98 M(-38.2%) |
| Jan 2015 | - | -$2.87 M(-29.3%) | -$19.39 M(-2.1%) |
| Oct 2014 | - | -$4.05 M(+90.8%) | -$19.81 M(+10.9%) |
| Jul 2014 | - | -$2.13 M(-79.5%) | -$17.87 M(+3.1%) |
| Apr 2014 | -$17.33 M(+234.7%) | -$10.34 M(+215.3%) | -$17.33 M(+110.8%) |
| Jan 2014 | - | -$3.28 M(+55.2%) | -$8.22 M(+25.9%) |
| Oct 2013 | - | -$2.11 M(+33.0%) | -$6.53 M(+27.9%) |
| Jul 2013 | - | -$1.59 M(+28.6%) | -$5.11 M(-1.4%) |
| Apr 2013 | -$5.18 M(-37.6%) | -$1.24 M(-22.3%) | -$5.18 M(-10.6%) |
| Jan 2013 | - | -$1.59 M(+130.7%) | -$5.79 M(-5.9%) |
| Oct 2012 | - | -$689.80 K(-58.5%) | -$6.16 M(-18.2%) |
| Jul 2012 | - | -$1.66 M(-10.3%) | -$7.53 M(-9.3%) |
| Apr 2012 | -$8.30 M | -$1.85 M(-5.3%) | -$8.30 M(-6.5%) |
| Jan 2012 | - | -$1.96 M(-4.9%) | -$8.87 M(-8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2011 | - | -$2.06 M(-15.4%) | -$9.67 M(+0.0%) |
| Jul 2011 | - | -$2.43 M(+0.3%) | -$9.67 M(-5.5%) |
| Apr 2011 | -$10.26 M(+0.6%) | -$2.43 M(-11.9%) | -$10.24 M(-1.4%) |
| Jan 2011 | - | -$2.75 M(+33.9%) | -$10.38 M(+0.0%) |
| Oct 2010 | - | -$2.06 M(-31.5%) | -$10.38 M(-4.9%) |
| Jul 2010 | - | -$3.00 M(+16.7%) | -$10.91 M(+7.0%) |
| Apr 2010 | -$10.20 M(+18.6%) | -$2.57 M(-6.6%) | -$10.20 M(+4.1%) |
| Jan 2010 | - | -$2.75 M(+6.4%) | -$9.80 M(+22.3%) |
| Oct 2009 | - | -$2.59 M(+12.9%) | -$8.01 M(+3.1%) |
| Jul 2009 | - | -$2.29 M(+5.7%) | -$7.76 M(-9.7%) |
| Apr 2009 | -$8.60 M(+193.3%) | -$2.17 M(+124.8%) | -$8.60 M(+9.6%) |
| Jan 2009 | - | -$963.50 K(-58.9%) | -$7.85 M(+1.4%) |
| Oct 2008 | - | -$2.34 M(-25.0%) | -$7.74 M(+36.0%) |
| Jul 2008 | - | -$3.13 M(+121.4%) | -$5.69 M(+94.2%) |
| Apr 2008 | -$2.93 M(+65.5%) | -$1.41 M(+64.6%) | -$2.93 M(+53.9%) |
| Jan 2008 | - | -$858.10 K(+188.4%) | -$1.91 M(+24.9%) |
| Oct 2007 | - | -$297.50 K(-18.5%) | -$1.53 M(-6.0%) |
| Jul 2007 | - | -$365.00 K(-5.3%) | -$1.62 M(-8.4%) |
| Apr 2007 | -$1.77 M(-28.5%) | -$385.50 K(-19.3%) | -$1.77 M(-6.8%) |
| Jan 2007 | - | -$477.70 K(+21.1%) | -$1.90 M(-8.8%) |
| Oct 2006 | - | -$394.50 K(-23.4%) | -$2.09 M(-12.3%) |
| Jul 2006 | - | -$514.70 K(-0.2%) | -$2.38 M(-4.1%) |
| Apr 2006 | -$2.48 M(-7.7%) | -$515.80 K(-22.0%) | -$2.48 M(-7.4%) |
| Jan 2006 | - | -$660.90 K(-3.7%) | -$2.68 M(-8.0%) |
| Oct 2005 | - | -$686.10 K(+11.4%) | -$2.91 M(+3.0%) |
| Jul 2005 | - | -$615.80 K(-13.9%) | -$2.83 M(+5.2%) |
| Apr 2005 | -$2.68 M(+18.4%) | -$715.30 K(-19.9%) | -$2.68 M(+7.6%) |
| Jan 2005 | - | -$893.30 K(+48.7%) | -$2.49 M(+3.2%) |
| Oct 2004 | - | -$600.90 K(+26.5%) | -$2.42 M(+5.8%) |
| Jul 2004 | - | -$475.10 K(-9.5%) | -$2.28 M(+0.7%) |
| Apr 2004 | -$2.27 M(-0.3%) | -$524.70 K(-35.7%) | -$2.27 M(+8.7%) |
| Jan 2004 | - | -$815.50 K(+74.4%) | -$2.09 M(+19.6%) |
| Oct 2003 | - | -$467.60 K(+1.8%) | -$1.74 M(-24.7%) |
| Jul 2003 | - | -$459.40 K(+33.9%) | -$2.32 M(+1.9%) |
| Apr 2003 | -$2.27 M(-36.9%) | -$343.20 K(-27.5%) | -$2.27 M(-41.9%) |
| Jan 2003 | - | -$473.60 K(-54.4%) | -$3.92 M(-0.7%) |
| Oct 2002 | - | -$1.04 M(+149.4%) | -$3.94 M(+14.0%) |
| Jul 2002 | - | -$416.90 K(-79.0%) | -$3.46 M(-4.0%) |
| Apr 2002 | -$3.60 M(+80.0%) | -$1.99 M(+296.1%) | -$3.61 M(+64.8%) |
| Jan 2002 | - | -$501.10 K(-10.0%) | -$2.19 M(+0.4%) |
| Oct 2001 | - | -$556.70 K(-1.1%) | -$2.18 M(-1.9%) |
| Jul 2001 | - | -$562.90 K(-0.7%) | -$2.22 M(+10.9%) |
| Apr 2001 | -$2.00 M(+119.6%) | -$566.90 K(+15.2%) | -$2.00 M(+8.4%) |
| Jan 2001 | - | -$492.00 K(-17.9%) | -$1.85 M(+26.9%) |
| Oct 2000 | - | -$599.50 K(+74.4%) | -$1.45 M(+37.9%) |
| Jul 2000 | - | -$343.80 K(-16.5%) | -$1.06 M(+48.3%) |
| Apr 2000 | -$911.60 K(+1.3%) | -$411.60 K(+311.6%) | -$711.60 K(+137.2%) |
| Jan 2000 | - | -$100.00 K(-50.0%) | -$300.00 K(+50.0%) |
| Oct 1999 | - | -$200.00 K(<-9900.0%) | -$200.00 K(<-9900.0%) |
| Jul 1999 | - | $0.00 | $0.00 |
| Apr 1999 | -$900.00 K(-28.4%) | - | - |
| Apr 1998 | -$1.26 M(-33.8%) | - | - |
| Apr 1997 | -$1.90 M(-19.1%) | - | - |
| Apr 1996 | -$2.35 M | - | - |
FAQ
- What is Tenax Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tenax Therapeutics?
- What is Tenax Therapeutics annual EBIT year-on-year change?
- What is Tenax Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly EBIT year-on-year change?
- What is Tenax Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tenax Therapeutics?
- What is Tenax Therapeutics TTM EBIT year-on-year change?
What is Tenax Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TENX is -$7.69 M
What is the all time high annual EBIT for Tenax Therapeutics?
Tenax Therapeutics all-time high annual earnings before interest & taxes is -$900.00 K
What is Tenax Therapeutics annual EBIT year-on-year change?
Over the past year, TENX annual earnings before interest & taxes has changed by +$3.36 M (+30.40%)
What is Tenax Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TENX is -$3.95 M
What is the all time high quarterly EBIT for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly earnings before interest & taxes is $0.00
What is Tenax Therapeutics quarterly EBIT year-on-year change?
Over the past year, TENX quarterly earnings before interest & taxes has changed by -$163.30 K (-4.31%)
What is Tenax Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TENX is -$14.54 M
What is the all time high TTM EBIT for Tenax Therapeutics?
Tenax Therapeutics all-time high TTM earnings before interest & taxes is $0.00
What is Tenax Therapeutics TTM EBIT year-on-year change?
Over the past year, TENX TTM earnings before interest & taxes has changed by -$4.46 M (-44.22%)